Total Payments
$676.39
2024 Payments
$234.68
Companies
16
Transactions
35
Medicare Patients
1,733
Medicare Billing
$80,819
Payment Breakdown by Category
Food & Beverage$676.39 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $676.39 | 35 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $87.24 | 4 | $0 (2019) |
| Biohaven Pharmaceuticals, Inc. | $77.62 | 3 | $0 (2021) |
| Novo Nordisk Inc | $59.30 | 4 | $0 (2021) |
| Bayer Healthcare Pharmaceuticals Inc. | $55.14 | 3 | $0 (2024) |
| ABBVIE INC. | $54.60 | 3 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $46.54 | 2 | $0 (2024) |
| Amgen Inc. | $45.77 | 3 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $45.10 | 2 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $45.01 | 2 | $0 (2022) |
| PFIZER INC. | $37.48 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $234.68 | 12 | Boehringer Ingelheim Pharmaceuticals, Inc. ($46.54) |
| 2023 | $24.64 | 1 | ABBVIE INC. ($24.64) |
| 2022 | $74.24 | 4 | Biohaven Pharmaceutical Holding Company Ltd. ($45.01) |
| 2021 | $168.98 | 8 | Biohaven Pharmaceuticals, Inc. ($77.62) |
| 2019 | $173.85 | 10 | Lilly USA, LLC ($87.24) |
All Payment Transactions
35 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/22/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $29.03 | General |
| Category: Respiratory | ||||||
| 11/19/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/14/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: Cardio-renal | ||||||
| 10/25/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $25.19 | General |
| Category: DIABETES | ||||||
| 10/03/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: Cardio-renal | ||||||
| 03/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: NEUROSCIENCE | ||||||
| 02/11/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $21.35 | General |
| 01/17/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: VACCINES | ||||||
| 01/10/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: Inflammation/Rare Disease | ||||||
| 01/03/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: Biological | ||||||
| 12/05/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.64 | General |
| Category: NEUROSCIENCE | ||||||
| 09/01/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: NEUROSCIENCE | ||||||
| 07/06/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $22.61 | General |
| Category: PRIMARY CARE | ||||||
| 04/27/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $12.92 | General |
| Category: Cardio-renal | ||||||
| 02/16/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: PRIMARY CARE | ||||||
| 11/17/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $44.22 | General |
| Category: PRIMARY CARE | ||||||
| 10/13/2021 | GlaxoSmithKline, LLC. | BOOSTRIX (Biological) | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: VACCINES | ||||||
| 09/29/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: Cardiovascular | ||||||
| 09/28/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: Diabetes | ||||||
| 07/22/2021 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: Endocrinology | ||||||
| 04/27/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: PRIMARY CARE | ||||||
| 03/02/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $12.20 | General |
| Category: PRIMARY CARE | ||||||
| 01/27/2021 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 23 | 929 | 1,385 | $95,120 | $27,869 |
| 2021 | 17 | 493 | 696 | $62,819 | $36,101 |
| 2020 | 8 | 311 | 386 | $30,812 | $16,849 |
Total Patients
1,733
Total Services
2,467
Medicare Billing
$80,819
Procedure Codes
48
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 90 | 132 | $29,040 | $9,662 | 33.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 42 | 48 | $14,304 | $5,749 | 40.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 29 | 32 | $4,704 | $2,140 | 45.5% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 83 | 117 | $4,095 | $1,212 | 29.6% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 35 | 37 | $3,300 | $1,081 | 32.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 18 | 18 | $3,924 | $1,031 | 26.3% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 44 | 57 | $3,819 | $947.74 | 24.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 88 | 124 | $3,348 | $925.41 | 27.6% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 45 | 45 | $1,800 | $738.42 | 41.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 42 | 88 | $6,424 | $736.66 | 11.5% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 49 | 54 | $2,376 | $702.75 | 29.6% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 16 | 32 | $1,248 | $465.10 | 37.3% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 20 | 21 | $3,318 | $454.78 | 13.7% |
| 82306 | Vitamin d-3 level | Office | 2022 | 12 | 14 | $1,540 | $409.93 | 26.6% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2022 | 22 | 24 | $1,368 | $357.72 | 26.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 82 | 122 | $4,392 | $351.60 | 8.0% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 27 | 33 | $1,122 | $297.43 | 26.5% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2022 | 26 | 29 | $580.00 | $172.70 | 29.8% |
| 81003 | Automated urinalysis test | Office | 2022 | 61 | 73 | $584.00 | $152.02 | 26.0% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2022 | 27 | 30 | $510.00 | $148.72 | 29.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 12 | 12 | $840.00 | $105.62 | 12.6% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2022 | 24 | 58 | $1,904 | $17.31 | 0.9% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 35 | 185 | $580.00 | $9.47 | 1.6% |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | Office | 2021 | 51 | 51 | $22,950 | $22,851 | 99.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 55 | 63 | $13,858 | $5,802 | 41.9% |
About Dr. Donna Haney, M.D
Dr. Donna Haney, M.D is a Family Medicine healthcare provider based in Zebulon, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1497821862.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Donna Haney, M.D has received a total of $676.39 in payments from pharmaceutical and medical device companies, with $234.68 received in 2024. These payments were reported across 35 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($676.39).
As a Medicare-enrolled provider, Haney has provided services to 1,733 Medicare beneficiaries, totaling 2,467 services with total Medicare billing of $80,819. Data is available for 3 years (2020–2022), covering 48 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Zebulon, GA
- Active Since 11/28/2006
- Last Updated 06/29/2010
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1497821862
Products in Payments
- NURTEC ODT (Drug) $122.63
- JARDIANCE (Drug) $66.08
- Kerendia (Drug) $55.14
- ELIQUIS (Drug) $37.48
- Ozempic (Drug) $35.16
- BASAGLAR (Drug) $31.66
- AIRSUPRA (Drug) $29.03
- VRAYLAR (Drug) $24.64
- Saxenda (Drug) $24.14
- Vascepa (Drug) $24.00
- Korlym (Drug) $18.96
- TRINTELLIX (Drug) $18.41
- CONTRAVE (Drug) $17.50
- Aimovig (Biological) $16.90
- QULIPTA (Drug) $16.31
- FARXIGA (Drug) $16.07
- Veozah (Drug) $15.31
- SHINGRIX (Biological) $14.82
- KRYSTEXXA (Biological) $14.80
- TRULICITY (Drug) $14.69
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Zebulon
Dr. Theodore Derse, Md, MD
Family Medicine — Payments: $313.68
Family Medicine $313.68
Octavia Graham, Md, MD
Family Medicine — Payments: $212.91
Family Medicine $212.91
Dr. Christopher Wozniak, D.o, D.O
Family Medicine — Payments: $122.58
Family Medicine $122.58
Tom John Mayuga, Do, DO
Family Medicine — Payments: $61.81
Family Medicine $61.81
Dr. Marcella Mccord, Md, MD
Family Medicine
Family Medicine
Henry Mascarenhas, Dnp, DNP
Family Medicine
Family Medicine